期刊文献+

益生菌在婴幼儿消化道炎症性和功能性疾病中应用进展 被引量:3

Progress on application of probiotics in inflammatory and functional diseases of digestive tract in infants and young children
下载PDF
导出
摘要 微生态稳定失衡使儿童免疫功能的发育及成熟受阻,进而影响免疫力,其与多种消化系统疾病的发生、发展和转归密切相关。益生菌可通过调节肠道菌群平衡、提高免疫力、减轻炎性损害、减少有害物质吸收等多种机制,在婴幼儿腹泻、炎症性肠病、坏死性小肠结肠炎、功能性腹痛疾病等的治疗中发挥重要作用。文章综述最新文献,以探讨益生菌在婴幼儿消化道炎症性和功能性疾病中的疗效及安全性,为不同疾病有益菌株的选择提供参考。 The imbalance of microecological stability hinders the development and maturity of immune function in children,which affects immunity and closely related to the occurrence,development and outcome of a variety of digestive diseases.Probiotics can play an important role in the treatment of infantile diarrhea,inflammatory bowel disease,necrotizing enterocolitis,functional abdominal pain by regulating the balance of intestinal flora,improving immunity,reducing inflammatory damage and reducing the absorption of harmful substances.This article intends to explore the efficacy and safety of probiotics in children's digestive system diseases through the latest literature research,so as to provide reference for the selection of beneficial strains fordifferent diseases.
作者 陈钰波(综述) 李宇宁(审校) CHEN Yubo;LI Yuning(The First Clinical Medical College of Lanzhou University;Department of Pediatrics,The First Hospital of Lanzhou University,Lanzhou 730000,Gansu,China)
出处 《临床儿科杂志》 CAS CSCD 北大核心 2022年第11期869-874,共6页 Journal of Clinical Pediatrics
关键词 消化系统疾病 益生菌 疗效 安全性 婴幼儿 digestive system diseases probiotics efficacy safety infant
  • 相关文献

参考文献7

二级参考文献83

  • 1Anna Chmielewska,Hania Szajewska.Systematic review of randomised controlled trials:Probiotics for functional constipation[J].World Journal of Gastroenterology,2010,16(1):69-75. 被引量:55
  • 2Ya-Ni Yin, Qiong-Fen Yu ,Xiao-Wei Liu, Fang-Gen Lu.Effects of four Bifidobacteria on obesity in high-fat diet induced rats[J].World Journal of Gastroenterology,2010,16(27):3394-3401. 被引量:16
  • 3Kotzampassi K,Giamarellos-Bourboulis EJ.Probiotics for infectious diseases:more drugs,less dietary supplementation[J].Int JAntimicrob Agents,2012,40(4):288-296.
  • 4Castellazzi AM,Valsecchi C,Caimmi S,et al.Probiotics and food allergy[J].Ital J Pediatr,2013(29):39-47.
  • 5Venugopalan V,Shriner KA,Wong-Beringer A.Regulatory oversight and safety of probiotic use[J].Emerg Infect Dis,2010,16(11):1661-1665.
  • 6Seale JV,Millar M.Probiotics:a new frontier for infection control[J].J Hosp Infect,2013,84(1):1-4.
  • 7Doron S,Snydman DR.Risk and safety of probiotics[J].Clin Infect Dis,2015,60(Suppl 2):S129-S134.
  • 8Boyle RJ,Robins-Browne RM,Tang MLK.Probiotic use in clinical practice:what are the risks[J].Am J Clin Nutr,2006,83(6):1256-1264.
  • 9Muoz P,Bouza E,Cuenca-Estrella M,et al.Saccharomyces cerevisiae fungemia:an emerging infectious disease[J].Clin Infect Dis,2005,40(11):1625-1634.
  • 10Hempel S,Newberry S,Ruelaz A,et al.Safety of probiotics used to reduce risk and prevent or treat disease[J].Evid Rep Technol Assess(Full Rep),2011(200):1-645.

共引文献33

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部